0A05.LSE Medacta Group S.A.

Healthcare Commercial Services & Supplies London Exchange
- CHF
Market cap
-
P/E
45.5x
P/B
-
ROE
34.4%
Dividend yield
0.24%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 0A05.LSE undervalued?

Graham number

The Graham number of Medacta Group S.A. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Medacta Group S.A. fundamental analysis

No fundamental analysis for Medacta Group S.A. yet.

Medacta Group S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Medacta Group S.A.

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Full company profile